Let’s Address the Big Panda in the Room…Panda Health, That Is!

 

On “Healthcare Rethink,” a FinThrive podcast, host Brian Urban addresses the big panda in the room when he engages with Ryan Bengtson, the President & COO at Panda Health. They explore Panda Health’s mission to mitigate the overwhelming challenge healthcare systems face when evaluating and integrating digital health solutions.

Bengtson shares his journey from healthcare consulting to leading Panda Health, detailing his experiences with Anderson Consulting and Huron Consulting Group before diving into the digital health sphere. The conversation highlights Panda Health’s dual approach: providing deep market intelligence on digital health solutions and creating a marketplace for pre-vetted technologies, significantly speeding up healthcare systems’ processes. They also discuss the impact of cybersecurity threats in healthcare and the strategic importance of robust evaluations before adopting new technologies. The episode covers Panda Health’s role in facilitating faster and safer digital health integration. It taps into broader topics, such as the future of patient flow automation and the potential for hospital-at-home models.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More